Nemaura Medical Inc. reveals attendance at this year’s HC Wainwright Global Investment Conference

  • Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices

  • The company recently announced its participation in the annual HC Wainwright Global Investment Conference, held September 13-15, 2021

  • With its flagship sugarBEAT, Nemaura has sought to capitalize on the growing market for type 2 diabetes, which is expected to reach an annual value of $59 billion by 2025.

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and marketing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs; The company’s flagship sugarBEAT(R) is a portable, non-invasive and flexible continuous glucose meter designed to help people with diabetes and prediabetes manage their glucose levels.

The management of Nemaura Medical recently announced their attendance at the 23rd Annual HC Wainwright Global Investment Conference, held in a fully digital forum between September 13-15, 2021 (https://ibn.fm/1OiBy). Founded in 1868, HC Wainwright is a…

Read more>>

NOTE TO INVESTORS: The latest news and updates related to NMRD are available in the company’s newsroom at: https://ibn.fm/NMRD

About BioMedWire

BioMedWire (BMW) is a biomedical news and content distribution company that (1) provides access to a network of wire services through InvestorWire to most effectively reach all target markets, sectors and demographics, (2) article and editorial syndication to over 5,000 news outlets (3), enhanced press releases to ensure maximum impact, (4) investor social media distribution Brand Network (IBN) to nearly 2 million followers, (5) a full suite of corporate communications solutions, and (6) a total news reporting solution with BMW Prime. As a multi-faceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies seeking to reach a broad audience of investors, consumers, journalists and the general public. By cutting through the information overload in today’s market, BMW offers its customers unparalleled visibility, recognition and brand awareness. BMW is where news, content and information come together.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (US cell phones only)

For more information, visit https://www.BioMedWire.com

Please refer to the full terms of use and disclaimers on the BioMedWire website that apply to all content provided by BMW, wherever published or republished: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Image by Jung Hoon Kim by Pixabay

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.